Form D · Other
Generian Pharmaceuticals, Inc.
Pittsburgh, PA · CIK 0001789827
Offering snapshot reported Oct 1, 2019 · SEC filing
- Reported sold
- $13M Offering amount: $20M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 20, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 1, 2019 | Initial | $12,989,999 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-350087
Source: Form D, filed Oct 1, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Beibei Chen | Director |
| Jeanne Cunicelli | Director |
| Toren Finkel | Director, Executive |
| Matthias Kleinz | Director |
| Hank Safferstein | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
2425 Sidney Street
Pittsburgh, PA, 15203
Pittsburgh, PA, 15203